|
|
Contracts:
Aligning Sponsor & CRO Interests
Lynn
Polgar
Associate Director,
US Contract Management Group
Covance
Purchase
recording US$199
|
|
Purchase
a recording of this audio conference
A
primary objective for the outsourcing and procurement divisions
of pharmaceutical and biotech companies is to select the best
CRO to undertake their project and deliver it to success. A primary
objective for the CRO is to deliver the project to success and
earn repeat business with the Sponsor. Both parties' core objective
is the same: to deliver the study to success. However, for both
organizations it is essential that the business objectives are
aligned and therefore, when entering into a Sponsor-CRO contractual
arrangement, there are various elements of risk to be considered
by both parties. This presentation, the last in a three-part series
on best practices for outsourcing, will focus on the components
of managing both legal and financial risk through effective contracting.
This audio
conference will address:
- Required
legal and financial terms, and why they are necessary
- Payment
terms and incentives
- Investigator
responsibility
- Timeline
management and responsibilities
- Scope creep
& change management
About the
speaker:
After spending
several years working within the pharmaceutical industry, Lynn
Polgar has been with Covance for the past five years. She currently
manages the US Contract Management group, and took over the position
of Associate Director in 2006. In that role, she oversees the
group responsible for negotiating and finalizing contracts starting
from pre-bid (Confidentiality Agreements) to post-award (LOIs,
Clinical Services Agreements and MSAs) through contract maintenance
(inclusive of change management). Lynn received her Bachelor of
Arts degree in Economics from Moravian College.
Who should
attend?
- Outsourcing
Representatives
- Contract
Managers (Sponsor-CRO contracts)
- Legal
Representatives
- Operational
Managers
Registration
Options
|